TNFSF10 and neoplasm: Platelet membrane‐coated particles have recently been investigated for use as drug delivery vehicles to both tumors and circulating tumor cells.190 The nanoformulation was both loaded with doxorubicin and conjugated with tumor necrosis factor‐related apoptosis inducing ligand (TRAIL); they efficiently localized to tumor cells in vivo, resulting in impressive control of both tumor growth and the amount of metastatic nodules in the lung.